Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies

doi:10.3748/wjg.v21.i38.10874

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 38

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7232)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

417

WORD

276

HTML

3248

Figures (1-5)

135

Tables (1-4)

121

Sum=4197

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1149

Download

1886

Sum=3035

Oct 14, 2015 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Oct 14, 2015; 21(38): 10874-10882
Published online Oct 14, 2015. doi: 10.3748/wjg.v21.i38.10874

Table 3 Multivariate analyses of clinical factors affecting one-year virologic response

	RR	95%CI	P value
Duration of ETV therapy (mo)	1.039	0.936-1.153	0.473
Serum HBV DNA level (< 5.2 log₁₀ IU/mL)	7.614	1.160-49.986	0.034
Presence of IVR-3	24.862	2.398-257.781	0.007

ETV: Entecavir; HBV: Hepatitis B virus; IVR-3: Initial virologic response at 3 mo.

Citation: Kim HS, Yim HJ, Jang MK, Park JW, Suh SJ, Seo YS, Kim JH, Kim BH, Park SJ, Lee SH, Kim SG, Kim YS, Lee JI, Lee JW, Kim IH, Kim TY, Kim JW, Jeong SH, Jung YK, Park H, Group SGHOBOARS. Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies. World J Gastroenterol 2015; 21(38): 10874-10882
URL: https://www.wjgnet.com/1007-9327/full/v21/i38/10874.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i38.10874